GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Aldawaa Medical Services Co (SAU:4163) » Definitions » Debt-to-EBITDA

Aldawaa Medical Services Co (SAU:4163) Debt-to-EBITDA : 2.46 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Aldawaa Medical Services Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Aldawaa Medical Services Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ﷼789 Mil. Aldawaa Medical Services Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ﷼1,405 Mil. Aldawaa Medical Services Co's annualized EBITDA for the quarter that ended in Mar. 2024 was ﷼892 Mil. Aldawaa Medical Services Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 2.46.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Aldawaa Medical Services Co's Debt-to-EBITDA or its related term are showing as below:

SAU:4163' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.58   Med: 3.31   Max: 3.34
Current: 2.58

During the past 3 years, the highest Debt-to-EBITDA Ratio of Aldawaa Medical Services Co was 3.34. The lowest was 2.58. And the median was 3.31.

SAU:4163's Debt-to-EBITDA is ranked better than
50.35% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 2.63 vs SAU:4163: 2.58

Aldawaa Medical Services Co Debt-to-EBITDA Historical Data

The historical data trend for Aldawaa Medical Services Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aldawaa Medical Services Co Debt-to-EBITDA Chart

Aldawaa Medical Services Co Annual Data
Trend Dec21 Dec22 Dec23
Debt-to-EBITDA
3.31 3.34 2.76

Aldawaa Medical Services Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.02 2.81 2.94 2.68 2.46

Competitive Comparison of Aldawaa Medical Services Co's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, Aldawaa Medical Services Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aldawaa Medical Services Co's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aldawaa Medical Services Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Aldawaa Medical Services Co's Debt-to-EBITDA falls into.



Aldawaa Medical Services Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Aldawaa Medical Services Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(846.151 + 1448.098) / 830.435
=2.76

Aldawaa Medical Services Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(789.247 + 1405.303) / 892.152
=2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Aldawaa Medical Services Co  (SAU:4163) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Aldawaa Medical Services Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Aldawaa Medical Services Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Aldawaa Medical Services Co (SAU:4163) Business Description

Traded in Other Exchanges
N/A
Address
Prince Naif Street. Cross 23, P.O. Box 4326, Al Khobar, SAU, 31952
Aldawaa Medical Services Co is engaged in the sale of pharmaceuticals and related products. It is focused on selling Taped Diapers, Pants Diapers, Baby Food, Body Cream, Diabetic Monitoring, Insulin Pen Needle, Blood Pressure Monitor, Nebulizers, Thermometers, Cough Medicines, and Nasal Decongestant Medicines, among other products. The company's segment includes Retail and Wholesale. It generates maximum revenue from the Retail segment.

Aldawaa Medical Services Co (SAU:4163) Headlines

No Headlines